2019-2022 Patient Problem analysis as reported to FDA We are trying to find major keyword patterns across device problems and patient problems that are also present in the B5 and H10 text of MDR reports The most frequent keywords are tracked using counters This exercise is also done by year to see any consistencies or
FDA Received over 2 Million MDRs in 2021 The Coronavirus pandemic did not stop the growth of MDRs reported to the Food and Drug Administration. The long term trend of 20% annual growth has continued in 2021. Over 2 Million MDRs (Adverse Events or serious malfunctions) were reported to the FDA. This is staggering as
Patient Infections reported to the FDA are showing an increase in both absolute and relative numbers. Specifically, over the past 10 years the number of infections reported has increased an average of 28% annually. If you narrow the range to the past 3 years only, the rate of increase jumps to an average of 55%.
MDR submitted to the FDA are showing an increase in the number of patient strokes (Cerebrovascular Accidents/CVA). The increase is in both absolute and relative numbers. Specifically, over the past 10 years the number of strokes reported has increased an average of 17%. If you narrow the range to the past 3 years only, the
Medical Device Reports (MDRs) are typically required to be submitted to the FDA within 30 days of Complaint Awareness. FDA utilizes a variety of Code Types to classify these MDRs. One of these code types is Patient Code which is being split into Health Effect - Clinical Codes and Health Effect - Impact Codes. One
Can MDRs predict when and if a medical device recall will happen? Based on our analysis, one can sometimes tell if a medical device safety recall is about to happen by the sudden big increase in submitted MDRs. As an example, here are 2 separate recalls reported by Allergan in 2019. Recall 1: Because of
One of the projects we have been working on is to take the MAUDE data from the FDA and clean it up. We linked this data to the device registrations and created our own database of parent companies. We looked at what the top MDR submitters were between 2010 and 2019 and some of the
Smarteeva announced the release of its Winter 2021 Post Market Surveillance Suite. Santa Barbara CA - Smarteeva announced the release if it's Winter 2021 Post Market Surveillance Suite which will have enhancements to its Smart Complaint System, FDA MDR Reporting, EU MIR Reporting, and Recall Management. Some of these enhancements include, MDR QuickFill, EUMIR QuickFill,
INCREASING MDR VOLUME FOR MEDICAL DEVICE COMPANIES IN THE UNITED STATES Changes in regulatory requirements in both the United States and Europe, along with an increase in healthcare utilization, have significantly increased the number of MDR reports sent to the FDA. New innovation is a necessity if companies want to effectively handle the onslaught of
Smarteeva announced the release of its Summer 2020 Post Market Surveillance Suite. Santa Barbara CA - Smarteeva announced the release if it's Summer 2020 Post Market Surveillance Suite which will have additional state of the art enhancements to its Smart Complaint System, HHE management, MDR Management, and Recall Management. Some of these enhancements include,
